Canada Markets open in 9 hrs 6 mins
  • S&P/TSX

    17,909.03
    -49.07 (-0.27%)
     
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • DOW

    30,814.26
    -177.24 (-0.57%)
     
  • CAD/USD

    0.7823
    -0.0031 (-0.3990%)
     
  • CRUDE OIL

    51.95
    -0.41 (-0.78%)
     
  • BTC-CAD

    44,781.40
    -853.38 (-1.87%)
     
  • CMC Crypto 200

    682.02
    -53.12 (-7.23%)
     
  • GOLD FUTURES

    1,827.80
    -2.10 (-0.11%)
     
  • RUSSELL 2000

    2,123.20
    -32.15 (-1.49%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • NASDAQ futures

    12,766.00
    -36.25 (-0.28%)
     
  • VOLATILITY

    24.34
    +1.09 (+4.69%)
     
  • FTSE

    6,735.71
    -66.25 (-0.97%)
     
  • NIKKEI 225

    28,215.30
    -303.88 (-1.07%)
     
  • CAD/EUR

    0.6479
    -0.0021 (-0.32%)
     

Vaccine news latest: Oxford-AstraZeneca promising results, FDA authorizes Regeneron’s treatment

On Monday, AstraZeneca announced that its experimental coronavirus — which was developed in conjunction with U.K.'s University of Oxford — vaccine has shown an average efficacy of 70% in large-scale trials. Meanwhile, the FDA issued an EUA (emergency use authorization) for Regeneron's antibody cocktail to treat the coronavirus in high-risk patients. Yahoo Finance’s Anjalee Khemlani breaks down the latest on the vaccine news front.